Diane Marie Da Silva, PhD, MS
|
Title(s) | Assistant Professor of Research Obstetrics & Gynecology |
---|
School | Keck School of Medicine of USC |
---|
Phone | +1 323 442 3868 |
---|
vCard | Download vCard |
---|
|
|
Overview Dr. Da Silva's current research interests span multiple areas of study that include applying immune modulation strategies to enhance natural and vaccine-induced immunity against Human papillomavirus, investigating the molecular and cellular determinants in the tumor microenvironment that lead to cervical and ovarian cancer progression and metastasis, and assessing the clinical significance of the cervico-vaginal microbiota in relation to chronic inflammation and cervical precancerous lesion progression.
Dr. Da Silva has spent the past 15 years studying human papillomavirus (HPV) interactions with host immune cell receptors and immune escape mechanisms used by HPV, and has been involved with development of therapeutic vaccine strategies against HPV-induced cancers. She has broad expertise and skills associated with immunology, oncology and infectious disease research, immunotherapeutics, vaccine immunogenicity and efficacy, pre-clinical vaccine/adjuvant development, small animal syngeneic and xenograft tumor models, clinical translational research, and analysis of immune responses and biomarkers in human samples.
Dr. Da Silva is the course director for a newly developed undergraduate Introductory course in Modern Oncology and Cancer Biology for the USC Minor in Health Care Studies that started in Spring 2015.
Bibliographic
-
Skeate JG, Porras TB, Woodham AW, Jang JK, Taylor JR, Brand HE, Kelly TJ, Jung JU, Da Silva DM, Yuan W, Kast WM. Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection. J Gen Virol. 2016 Feb; 97(2):422-34. PMID: 26555393.
-
Da Silva DM, Woodham AW, Skeate JG, Rijkee LK, Taylor JR, Brand HE, Muderspach LI, Roman LD, Yessaian AA, Pham HQ, Matsuo K, Lin YG, McKee GM, Salazar AM, Kast WM. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. Clin Immunol. 2015 Dec; 161(2):197-208. PMID: 26360252; PMCID: PMC4658296 [Available on 12/01/16].
-
Da Silva DM, Movius CA, Raff AB, Brand HE, Skeate JG, Wong MK, Kast WM. Suppression of Langerhans cell activation is conserved amongst human papillomavirus a and ß genotypes, but not a µ genotype. Virology. 2014 Mar; 452-453:279-86. PMID: 24606705; PMCID: PMC3987942.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|